Suven Pharmaceuticals Limited Cash Flow Quality Index
Suven Pharmaceuticals Limited cash flow quality index. Suven Pharmaceuticals Limited (SUVENPHAR) has a Cash Flow Quality Index of 0.55x as of December 2023. Operating cash flow of Rs255.04 Million is below net income of Rs467.54 Million, suggesting accrual-heavy earnings not yet converted to cash. See Suven Pharmaceuticals Limited free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Suven Pharmaceuticals Limited (2019–2025)
Cash flow quality index of Suven Pharmaceuticals Limited from 2019 to 2025. Historical Cash Flow Quality Index for Suven Pharmaceuticals Limited across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore SUVENPHAR debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Suven Pharmaceuticals Limited Cash Flow Quality Index by Year (2019–2025)
Suven Pharmaceuticals Limited cash flow quality index by year from 2019 to 2025. Year-by-year earnings quality comparison for Suven Pharmaceuticals Limited. For the full cash flow conversion analysis, see Suven Pharmaceuticals Limited (SUVENPHAR) cash flow conversion.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.84x | Rs2.88 Billion | Rs3.44 Billion | ▼ -29.8% |
| 2024 | 1.19x | Rs3.58 Billion | Rs3.00 Billion | ▲ +48.2% |
| 2023 | 0.81x | Rs4.51 Billion | Rs5.60 Billion | ▲ +63.0% |
| 2022 | 0.49x | Rs3.30 Billion | Rs6.68 Billion | ▼ -39.7% |
| 2021 | 0.82x | Rs3.83 Billion | Rs4.68 Billion | ▼ -20.3% |
| 2020 | 1.03x | Rs4.16 Billion | Rs4.05 Billion | ▲ +222.1% |
| 2019 | 0.32x | Rs504.05 Million | Rs1.58 Billion | — |